Priority Lane: Guidances On Risky Devices, 510(k) Reform Top FDA’s To-Do List
Executive Summary
The US FDA hopes to finalize or issue draft guidance documents on about 30 topics in fiscal year 2021.
You may also be interested in...
Merit Medical To Pay $18M To Settle Kickback Case
The US Department of Justice says the company provided advertising assistance and educational grants to health care providers that used its embolization devices.
Device Week, 16 October 2020 – FDA Drops 3 Guidance Docs
On this week’s podcast: The US FDA was busy with draft and final guidance documents this week, issuing three within 24 hours. The docs address disparate device industry concerns, ranging from of-the-moment issues like coronavirus test supplies, to more traditional concerns around device materials testing.
Citing Shortages Tied To COVID-19, FDA Allows Some Alternative Flu Test Materials
The agency won’t require a 510(k) if manufacturers make some substitutions for materials now in high demand for COVID-19 tests.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: